By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fox Chase Cancer Center 

333 Cottman Avenue

Philadelphia  Pennsylvania  19111-2497  U.S.A.
Phone: 888-369-2427 Fax: n/a




Company News
Fox Chase Cancer Center Study: Pancreatic And Kidney Cancers Contain Noncancerous Niches That May Be Manipulated To Hinder Tumor Growth 1/31/2017 8:59:44 AM
Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies 9/13/2016 9:31:49 AM
Fox Chase Cancer Center Researchers Use New Methodology To Identify Neighborhood Variables Associated With Prostate Cancer Aggressiveness 4/15/2016 9:19:24 AM
Review By Fox Chase Cancer Center -- Temple Health And Temple University School Of Medicine Physicians Highlights Advances In Diagnosis And Treatment Of Bile Ducts Cancers 1/22/2016 9:55:46 AM
Caris Life Sciences And Fox Chase Cancer Center - Temple Health Collaborate On Potential New Treatments For Triple-Negative Breast Cancer (TNBC) 12/8/2015 11:20:01 AM
Oncoceutics Release: Clinical Trial For ONC201 Begins At Fox Chase Cancer Center 11/30/2015 1:02:50 PM
Accutest And Fox Chase Cancer Center - Temple Health Form Strategic Partnership On Clinical Trials For Oncology 11/30/2015 6:40:46 AM
Fox Chase Cancer Center Release: Mutations That Predict Response To Therapy Could Guide Treatment Of Bladder Cancer 8/5/2015 10:05:32 AM
Horizon Pharma (HZNP) Announces Collaboration With Fox Chase Cancer Center To Study ACTIMMUNE (Interferon Gamma-1b) In Combination With PD-1/PD-L1 Inhibitors In Various Forms Of Cancer 7/27/2015 11:35:20 AM
Fox Chase Cancer Center To Conduct ONC201 Dose Intensification Trial 7/20/2015 9:39:34 AM